abstract |
The present invention discloses a stable pharmaceutical formulation of an antibody, wherein the formulation contains buffer, surfactant, sugar, and optionally contains a free amino acid. The disclosed formulation is stable at 50 ÂșC for two weeks. In addition, the formulation maintains at least 96% of the antibody in monomeric form under above said storage conditions. |